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ABSTRACT
Antimicrobial peptides (AMPs) are the most common immune effectors in invertebrates that functions as the first line of
defence against microbial infection. Scygonadin is an AMP which can be found in the seminal plasma of Scylla serrata.
Preceding studies had shown that scygonadin have the ability to exhibit wide antimicrobial activities. Nonetheless, analysis
of the antimicrobial properties of scygonadin is significantly dependent on acquiring sufficient amounts of the protein from
mud crab, and this was proven difficult. Further functional studies of scygonadin and its commercial applications require a
development of efficient, sustainable and cost-effective heterologous protein production. To address this issue, an expression
plasmid containing 387 bp of scygonadin gene of Scylla serrata was cloned into pBAD/Myc-His A, expressed in TOP10
cells with L-arabinose as expression inducer, followed by protein purification by using immobilized metal affinity
chromatography (IMAC). The optimal expression condition was determined by incubation with 0.02% of L-arabinose for 4
hours at 37°C. A total of 2 mg/ml of purified scygonadin with the molecular weight of ~17kDa was succesfully obtained.
The results demonstrated that the recombinant scygonadin was successfully produced in heterologous expression system
which may allow production of scygonadin in large quantities for further research and commercial application.
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INTRODUCTION
Antimicrobial peptides (AMPs), the prominent
constituents in the innate immune system are crucial
in defending host species from microbial intrusion
(Peng et al., 2010). The innate immune system
pertained to the host mechanism defence against
microbes (Hoebe et al., 2004; Iwanaga & Lee, 2005).
AMPs protect the host from foreign substance via
protein-protein interaction to control transport
system (Chen et al., 2012). AMPs are also regarded
as promising antibiotic candidates due to its ability
to decrease the target cell’s resistance with extensive
range of mechanism of antibacterial actions
(Hancock & Patrzykat, 2002; Pushpanathan et al.,
2013). According to Aoki & Ueda (2013), extensive
range of AMPs antibacterial action includes
disruption of structural membrane, inhibition of
protein as well as DNA synthesis, and repression of
cellular process.
AMPs affect the bacteria by folding itself to
amphipathic secondary structure after binding with
negatively charge bacterial membrane and hence
causing bacterial death through physical, chemical
or biological processes (Chen et al., 2012). AMPs
also inhibits virus replication by incorporating with
virus envelope, minimize virus’s binding ability
and intercept viral entry by dominating the
binding receptor on host cell [reviewed by Bahar
and Ren (2013)]. Interestingly, bacteria are unlikely
to acquire resistance towards AMPs due to its
multifaceted mechanism of actions and ability to kill
within a short time. Collectively, these properties
makes AMPs, an exquisite therapeutic candidate
replacing existing antibiotics [reviewed by
Malanovic and Lohner (2016)].
Scygonadin, an AMP originated from the
seminal plasma of mud crab, Scylla serrata has
accounted for antibacterial activities against
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Micrococcus luteus and Aeromonas hydrophila
(Huang et al., 2006). A study conducted by Peng et
al. (2012) demonstrated that scygonadin exhibited
antiviral activity against White spot syndrome virus
(WSSV) by interfering with the virus replication in
vitro. Nevertheless, characterization of the full
potential of scygonadin requires a sufficient amount
of the protein in each study. Since extracting the
scygonadin protein from the fresh sample is often
limited due to time and requires maximum natural
resource contrary to the minimum amount of protein
extracted, the recombinant protein techniques were
used to overcome those limitations. By selecting
heterologous recombinant protein expression tool,
scalable protein production can be deployed,
enabling more proteins to be produced for
elucidating its functional and biological properties.
Hence, in this study, a recombinant scygonadin
AMPs expression system was designed with
optimized purified protein production.
MATERIALS AND METHODS
Cloning of scygonadin into pBAD/Myc-His A
expression vector
The construction of scygonadin pBAD/Myc-His
A expression cassette (Figure 1) was carried out by
double digestion of full-length 387bp sequence
of scygonadin gene (GeneBank Accession No.
AY864802 and was synthesized by Bio-Diagnostic
Sdn. Bhd) and pBAD/Myc-His A vector with
restriction enzyme BgIII and HindIII (Promega), by
following manufacturer’s protocol. The expression
cassette contains a C-terminal polyhistidine (6xHis)
tag for nickel-chelating resin purification and Myc
tag to assist in detection with anti-Myc antibody in
Western blot.
The pBAD/Myc-His A vector was
dephosphorylated by incubation with 1U Rapid
Alkaline Phosphatase (RAP) at 37°C for 10 minutes,
followed by inactivation of the enzyme by
incubation at 75°C for 2 minutes. For ligation of
BgIII/HindIII-cut vector DNA and scygonadin gene
insert, approximately 60 ng of insert DNA and 20
ng of vector DNA were incubated with 1U T4 DNA
ligase (Roche) and 1X ligation buffer, in a final
volume of 40 µl for overnight at 4-8°C.
The expression plasmid encoding scygonadin
was transformed into chemically competent DH5α
Escherichia coli cells using conventional heat-
shock method. A total of 50 µl competent cells
DH5α were thawed on the ice and mixed with 1 µl
of ligation mixture. The mixture then was incubated
on ice for 30 minutes followed by heat-shock at
42°C for 30 seconds and placed on ice for 2 minutes.
Following that, a total of 1 ml of LB broth was
added and the mixture was further incubated at
37°C for 60 minutes. A total of 100 µl of the
transformed cells was spread onto 1.5 % (w/v) LB
agar containing 100 µg of ampicillin (AMRESCO)
per ml and incubated overnight at 37°C.
Screening of putative transformant with
scygonadin pBAD/Myc-His A plasmid
Putative transformants were subjected for
screening after 18 hours of incubation in LB broth
and proceeded to small scale preparation of plasmid
DNA by using PureYieldTM Plasmid Miniprep
System (Promega, USA). The putative recombinant
plasmid was treated with RE (HindIII) to confirm the
size of the plasmid. The putative plasmid with
correct size was sent for sequencing for sequence
verification.
Expression of recombinant scygonadin protein in
TOP10 cells
Prior to protein expression, the plasmid
encoding scygonadin were first transformed into
chemically competent TOP10 Escherichia coli cells
using the conventional heat-shock method.
A single colony of transformant containing
scygonadin pBAD/Myc-His A plasmid was
inoculated into 50 ml Falcon tube containing 10 ml
LB media with the addition of 50 µg/ml ampicillin
and incubated in a rotary shaker at the speed of 225
rpm for 16 hours at 37°C. The cultures were diluted
and grown further for 2 hours until OD600≈0.5,
before being induced with various concentration of
L-arabinose (Sigma-Aldrich) with the concentrations
of 0.1% 0.2%, 0.02%, 0.002%, 0.0002, and
0.00002%, respectively. The cultures were left for
Fig. 1. Schematic representation of recombinant scygonadin
pBAD/Myc His A expression plasmid.
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4, 8, 12 and 24 hours post-induction, respectively.
The pre and post-induction samples were collected
and were analysed with Sodium Dodecyl Sulphate
Polyacrylamide Gel Electrophoresis (SDS-PAGE)
and Western Blot.
Purification of recombinant scygonadin protein
using IMAC system (Thermo Fisher)
In order to optimize the purification of
scygonadin, a total of 100 ml, 500 ml and 1000 ml
of expressed cell culture were initially set up and
harvested by centrifugation. The cell then was
suspended in binding buffer (250 mM NaH2PO4;
2.5 M NaCl; pH 8) and a total of 8 mg lysozyme
(RBC Bioscience) was added into the solution
before incubation on ice for 30 minutes. Following
that, the solution was sonicated on ice using six
10-second bursts with 10-second cooling period
between each burst to lyse the cell. The cell lysate
was centrifuged at 3000 rpm for 15 minutes to pellet
the cellular debris.
The nickel-chelating resin column was prepared
by using 2 ml of resin and through a series of
washing using sterile distilled water and binding
buffer (250 mM NaH2PO4; 2.5 M NaCl; pH 8). A
total of 8 ml of lysate prepared from 100 ml, 500
ml and 1000 ml culture, respectively, was added into
each prepared column with nickel-chelating resin
and allowed for binding overnight at room
temperature using gentle agitation to keep the resin
suspended in the solution. Then, the resin was
washed with wash buffer (250 mM NaH2PO4; 2.5 M
NaCl; 20 mM imidazole; pH 8 and the protein was
eluted with 8ml of elution buffer (250 mM
NaH2PO4; 2.5 M NaCl; 250 mM imidazole; pH 8).
The protein sample was stored at 4°C until further
analysis.
Analysis of expressed protein by SDS-PAGE and
Western blot
In the SDS-PAGE procedure, the cell pellet was
first lysed with lysis buffer (10 mM Tris-HCI, pH 8,
1 mM EDTA, 0.5 mg/ml lysozyme, 10 mM CaCl2).
A total of 40 µg of scygonadin protein from
expression and purification steps were loaded into
4-12% precast gel (Novex, Invitrogen). The gel was
run at 200V for 40 minutes and then stained with
Coomassie Brilliant Blue R-250 for SDS-PAGE.
While for Western Blot, the gel was proceeded to
blotting onto nitrocellulose membrane using semi-
dry blot machine (Biorad). Then the membrane was
blotted with Myc tag monoclonal-Horseradish
Peroxidase (HRP) conjugate antibody (diluted in
1:1000 in 10 ml of Tris-saline buffer) and developed
by using 3,3’,5,5’-tetramethylbenzidine (TMB)
substrate solution.
RESULTS & DISCUSSION
Recombinant scygonadin plasmid DNA extraction
and purification
The generation of scygonadin pBAD/Myc His
A expression vector was confirmed by agarose
gel electrophoresis after enzymatic digestion with
a single RE (HindIII). The result from agarose gel
electrophoresis exhibited a linear plasmid with
expected size of approximately 4.4kb (Figure 2).
The presence of scygonadin gene was also verified
by sequencing whereby the full-length of 387bp
scygonadin are present. The obtained sequence
result was also verified by BLAST (GeneBank
Accession No. AY864802).
Optimisation of scygonadin pBAD/Myc His A
expression system
Successful heterologous protein expression
system often requires optimum amount of inducer
and ideal time of induction. Here in this study, the
parameter of L-arabinose inducer concentration
and time of induction were carefully evaluated.
Considering a possibility of toxicity of AMPs
against the bacterial cells (host) and the use of
pBAD/Myc His A as the backbone vector,
compatible TOP10 competent cells were selected as
the strain of choice in which these cells are more
effective on araBAD protein expression. Some of the
notable advantages of using pBAD promoter system
with regulator of Ara C are that, the eminent protein
expression level can be achieved using inducer and
can be regulated over extensive range of inducer
concentration (Guzman et al., 1995).
The protein expression in the competent cells
containing scygonadin pBAD/Myc-His A was
induced by L-arabinose with various concentrations
of 0.1% 0.2%, 0.02%, 0.002%, 0.0002, and
Fig. 2. Gel electrophoresis analysis for RE digested
scygonadin pBAD/Myc His A expression plasmid (lane M:
1kb Quick-load DNA ladder; Lane 1: scygonadin pBAD/
Myc His A digested with HindIII.
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0.00002%, respectively. The induction time of the
L-arabinose was also optimized to 4 hours, 8 hours,
12 hours and 24 hours. Based on Figure 3, a soluble
recombinant scygonadin protein around 17kDa was
successfully expressed in TOP10 cells. There is an
increase in the expression between the uninduced
sample and the sample that has been induced with
L-arabinose for 4 hours to 24 hours. From this
experiment, it is found that the protein from 4 hours
of post-induction were highly expressed, while the
level of expressed protein decreasing over time. This
is possibly due to the expression of recombinant
protein contributed to a metabolic burden in the host
microorganism, making significant decrease of
protein production over time (Bentley et al.,1990;
Rosano & Ceccarelli, 2014). As for the differences
in inducer concentration, the scygonadin protein
was highly expressed in 0.02% of L-arabinose
compared to the other tested concentrations. This
was evident both on SDS-PAGE as well as by
protein quantitation by Bradford method (data not
shown). This finding is in line with the Zhang et al.
(2012) experiment using pBAD expression system,
where the expression level was enhanced by 10-
folds with low amount of L-arabinose inducer before
the level remained constant.
Purification of scygonadin using IMAC
In this study, the recombinant scygonadin
protein was purified using affinity chromatography
where the method utilizes protein with high affinity
for a particular chemical group (Berg et al., 2002).
This purification method involves recombinant
protein that carries a short affinity tag comprises
of polyhistidine residue that will interact with
transition metal ion like Co2+, Ni2+, Cu2+ or Zn2+
(Bornhorst & Falke, 2010).
The constructed scygonadin pBAD/Myc His A
expression plasmid was purposely designed to
contain C-terminal polyhistidine tag for aiding the
purification step using nickel-chelating resin, while
the Myc as the affinity tag for protein detection
in Western blot. The final elution of the sample
showed a single band of protein with the size of
17kDa, as detected using anti-Myc antibody since
the recombinant scygonadin protein contain a Myc
tag at the C-terminal.
Fig. 3. SDS-PAGE analysis of the scygonadin expression following different L-arabinose
inducer concentration. The sample was collected after (A) 4 hour, (B) 8 hour, (C) 12 hour,
and (D) 24 hour post-induction. The gel was stained with Coomassie Brilliant Blue R-250.
(M: Protein standard marker; 1: uninduced sample as control; 2-7: Post induction with
0.2%, 0.1%, 0.02%, 0.002%, 0.0002%, and 0. 00002% of L-arabinose, respectively). The
protein of interest (scygonadin) is indicated in arrow with the size of ~17kDa.
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In order to achieve higher protein yield, the
culture volume was set up with three different
volumes of 100ml, 500ml and 1000ml, respectively.
As shown in Figure 4, the volume of cell culture
harvested for protein purification significantly affect
the amount of the eluted protein where 1000ml
culture showed substantial amount of eluted protein
of 2mg/ml.
CONCLUSION
This study revealed that the scygonadin pBAD/Myc
His A protein expression system is a good
alternative in producing scygonadin protein in
vitro. The produced recombinant protein is able to
be purified through IMAC system without the
requirement of sophisticated purification setup. Due
to the efficient protein expression and the quantity
of the purified product, this system can be
considered as a highly sustainable system which
offers the potential for low-cost protein production
at a larger scale. As heterologous expression is
widely understood and easily manipulated, the
findings reported in this study enables further
functional analysis of the scygonadin with the
potential for commercial applications.
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Fig. 4. Western blot analysis of purified scygonadin protein
produced in different bacterial culture volumes. The protein
sample was collected from the TOP10 competent cell culture
after 4 hours post-induction with 0.02% of L-arabinose.
(M, Protein standard marker; 1-3: purified scygonadin from
100ml, 500ml and 1000ml volume cultures, respectively).
The protein of interest (scygonadin) is indicated in arrow
with the size of ~17kDa. The protein was detected by using
anti- Myc antibody.
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